Cargando…
A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I(1)-Imidazoline Receptor)
The association of cocaine use disorder (CUD) and comorbid major depressive disorder (MDD; CUD/MDD) is characterized by high prevalence and poor treatment outcomes. CUD/MDD may be primary (primary MDD) or cocaine-induced (CUD-induced MDD). Specific biomarkers are needed to improve diagnoses and ther...
Autores principales: | Keller, Benjamin, Mestre-Pinto, Joan-Ignasi, Álvaro-Bartolomé, María, Martinez-Sanvisens, Diana, Farre, Magí, García-Fuster, M. Julia, García-Sevilla, Jesús A., Torrens, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757145/ https://www.ncbi.nlm.nih.gov/pubmed/29326609 http://dx.doi.org/10.3389/fpsyt.2017.00258 |
Ejemplares similares
-
BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2022) -
The Tryptophan System in Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2020) -
Sex Differences in Psychiatric Comorbidity and Plasma Biomarkers for Cocaine Addiction in Abstinent Cocaine-Addicted Subjects in Outpatient Settings
por: Pedraz, María, et al.
Publicado: (2015) -
Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
por: Sanvisens, Arantza, et al.
Publicado: (2021) -
Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2019)